Johnson & Johnson MedTech has announced the U.S. Food and Drug Administration (FDA) approval of an update to the VARIPULSE ...

Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were ...

The move is the latest voluntary effort by U.S. food manufacturers to heed calls from the Trump administration to remove ...

Dozens of ice cream makers pledged on Monday to remove artificial dyes from their products by 2028. The move is the latest ...

A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

Each year, choking claims the lives of more than 4,100 Americans aged 65 or older. In response, several companies are ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced FDA approval for an update to its Varipulse platform's irrigation flow ...

Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...